The antineutrophil cytoplasmic antibodies (ANCA typical or not) in current medical practice

被引：4
|
作者：
Renaudineau, Y. [3 ]
Beauvillard, D. [3 ]
Segalen, I. [2 ,3 ]
Leroyer, C. [1 ]
Le Meur, Y. [2 ]
Youinou, P. [1 ]
机构：
[1] CHU Brest, Hop Cavale Blanche, Serv Pneumol, F-29609 Brest, France
[2] CHU Brest, Hop Cavale Blanche, Serv Nephrol, F-29609 Brest, France
[3] CHU Brest, Hop Morvan, Immunol Lab, F-29609 Brest, France
来源：
IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE | 2011年 / 26卷 / 01期
关键词：
Antineutrophil cytoplasmic antibodies (ANCA); Vasculitis; Proteinase; 3; Myeloperoxidase (MPO); INTERNATIONAL CONSENSUS STATEMENT; WEGENERS-GRANULOMATOSIS; NECROTIZING GLOMERULONEPHRITIS; CRESCENTIC GLOMERULONEPHRITIS; SYSTEMIC VASCULITIS; DISEASE-ACTIVITY; AUTOANTIBODIES; PROTEINASE-3; NEUTROPHILS; MYELOPEROXIDASE;
D O I：
10.1016/j.immbio.2010.12.002
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Antineutrophil cytoplasmic antibodies (ANCA) are important serological markers mostly for the small vessel systemic vasculitides. Numerous reports have established an interest for the combination of the indirect immunofluorescence (IFI) and the ELISA anti-PR3 and anti-MPO in such indication. However, conflicting results may exist between IFI and ELISA that require additional assays and such special measures are important to help and avoid clinical misinterpretation. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：27 / 34
页数：8
相关论文
共 50 条
  • [31] ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN INFLAMMATORY ARTHRITIS - POTENTIAL FOR MISDIAGNOSIS
    HELSLOOT, J
    VIRGO, S
    MCGUIGAN, L
    STURGESS, A
    BRITISH JOURNAL OF RHEUMATOLOGY, 1995, 34 (09): : 820 - 824
  • [32] Antineutrophil cytoplasmic antibodies in the classification of vasculitis
    Niles, JL
    ANNUAL REVIEW OF MEDICINE, 1996, 47 : 303 - 313
  • [33] Antineutrophil Cytoplasmic Antibodies Testing and Interpretation
    Allard-Chamard, Hugues
    Liang, Patrick
    CLINICS IN LABORATORY MEDICINE, 2019, 39 (04) : 539 - +
  • [34] Limited Antineutrophil Cytoplasmic Antibodies (ANCA)-Negative Granulomatosis With Polyangiitis: Successful Response to Rituximab
    Andrade, Maria Margarida
    Fernandes, Manuel
    Freire, Sara
    Cruz, Diogo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [35] SCREENING FOR ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) - IS INDIRECT IMMUNOFLUORESCENCE THE METHOD OF CHOICE
    BASLUND, B
    SEGELMARK, M
    WIIK, A
    SZPIRT, W
    PETERSEN, J
    WIESLANDER, J
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 99 (03) : 486 - 492
  • [36] Antineutrophil cytoplasmic antibodies (ANCA)-associated crescentic glomerulonephritis and propylthiouracil therapy
    Yuasa, S
    Hashimoto, M
    Yura, T
    Sumikura, T
    Takahashi, N
    Shoji, T
    Uchida, K
    Fujioka, H
    Kihara, M
    Matsuo, H
    NEPHRON, 1996, 73 (04): : 701 - 703
  • [37] Clinical value of antineutrophil cytoplasmic antibodies.
    Rus V.
    Handwerger B.S.
    Current Rheumatology Reports, 2000, 2 (5) : 383 - 389
  • [38] Childhood antineutrophil cytoplasmic antibodies associated vasculitides
    Twilt, Marinka
    Benseler, Susanne
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (01) : 50 - 55
  • [39] Twenty-eight years with antineutrophil cytoplasmic antibodies (ANCA): how to test for ANCA - evidence-based immunology?
    Csernok, Elena
    Holle, Julia U.
    AUTOIMMUNITY HIGHLIGHTS, 2010, 1 (01) : 39 - 43
  • [40] Anti-neutrophil cytoplasmic antibodies (ANCA): Antigen interactions and downstream effects
    Sundqvist, Martina
    Gibson, Kristen M.
    Bowers, Sarah M.
    Niemietz, Iwona
    Brown, Kelly L.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2020, 108 (02) : 617 - 626
12345